title: [SPECIFIC CLINICAL FEATURES OF TYPE 1 AUTOIMMUNE POLYGLANDULAR SYNDROME].
abstract: Autoimmune polyglandular syndrome is a primary autoimmune disorder affecting two or more peripheral endocrine glands and responsible for their incompetence. It is frequently combined with various organ-specific non-endocrine diseases. Patients with this pathology need life-long replacement therapy and dynamic observation by endocrinologists and other specialists to monitor the effectiveness of the treatment and detect new components of the disease. We report a variant of type 1 autoimmune polyglandular syndrome. Special emphasis is laid on the importance of succession of actions of endocrinologists and specialists in related medical disciplines dealing with children and adult patients.
authors.forename: M S
authors.initials: MS
authors.lastname: Mikhina
authors.forename: N V
authors.initials: NV
authors.lastname: Molashenko
authors.forename: E A
authors.initials: EA
authors.lastname: Troshina
authors.forename: E M
authors.initials: EM
authors.lastname: Orlova
authors.forename: L S
authors.initials: LS
authors.lastname: Sozaeva
authors.forename: S H
authors.initials: SH
authors.lastname: Eystein
authors.forename: S
authors.initials: S
authors.lastname: Breivik
mesh_terms: D000328:Adult; D015551:Autoimmunity; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use*; D020249:Hormone Replacement Therapy / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D016884:Polyendocrinopathies, Autoimmune / Q000276:immunology* / Q000628:therapy
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents